MRD / Regn No. : TL/20-21/00886 Date : 29/06/2026
Patient Name : Jalpa Shah Age & Gender : 50 Yrs. / Female
Contact No. : 9967488339 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (08/Jan/2002) | HYPOTHYROIDISM (06/Jan/2004) |
Subjective : T2DM X 20 YRS,HYPOTHYROIDISM SINCE 2004,LOT OF TRAVEL / FESTIVALS
Objective : 29-JUN-2026 REPORTS,FBS-102.61,TC-151.7/ TG-147.2/ LDL-75.96/ HDL-46.3,ALT-102.90/ AST-36.10,CR-0.57,CL-100,T3-1.17/ T4-11.51/ TSH-0.549,VITB12-1883,VITD-58.10,HB-13.3/ HBA1C-8.30%
Plan : HOLD DECLENTA FOR 2 WEEKS,CHECK FBS 2/WEEK - TARGET FBS 130  
S# Generic (Trade) Name Route Dosage Usage Duration
1 THYRONORM 100 MCG ORAL 1-0-0 BBF
4 MTHS
2 DRISE 60,000 ORAL 1/15 DAYS ANYTIME OF DAY
4 MTHS
3 AMANZA M3 ORAL 1-0-1 BBF / BD
4 MTHS
4 INJECTION DEGLUDEC (100IU/ML)
TRESIBA
SQ 0-0-24 BEDTIME
4 MTHS
5 NERVIHENZ ORAL 0-1-0 AL / 3 DAYS A WEEK
4 MTHS
6 ROZUCOR 10 MG ORAL 0-0-1 AD
4 MTHS
7 GLIPTOZA 1.8 MG SC 1.8 MG BBF
4 MTHS
8 CLINDAMYCIN AND CLOTRIMAZOLE VAGINAL SUPPOSITORIES
CANDID CL
VAGINAL 0-0-1 BEDTIME
6 NIGHTS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 11/Mar/2026
Tests Suggested For Next Visit : AFTER 4 MTHS - FBS / PPBS / HBA1C / TSH
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: